New updates have been reported about Take2.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Take2 has raised $14 million in Series A financing to accelerate deployment of its autonomous AI agents for healthcare recruiting, positioning the company to expand from interview automation into end-to-end hiring workflows. The round was led by Human Capital with participation from Bertelsmann Healthcare Investments, Reach Capital, SemperVirens VC, and Honeystone Ventures, providing growth capital to deepen Take2’s healthcare-specific capabilities and broaden its footprint with large U.S. health systems.
Built around its flagship AI Interviewer, Take2’s platform conducts and scores phone interviews around the clock, integrates directly with applicant tracking systems, and uses domain-specific data to generate predictive insights aimed at improving hiring quality and retention. With healthcare facing structurally high vacancy costs, more than 50% turnover in many roles, and heavily manual recruiting processes, Take2 plans to use the new funding to build a broader network of agents that automate sourcing, screening, credential checks, scheduling, and onboarding, targeting multi-million-dollar annual savings for customers while improving time-to-fill and candidate experience.